AbstrACt
Objective Within the last years, there has been growing awareness of the negative repercussions of unstandardized planning, conduct and reporting of preclinical and biomedical research. Several initiatives have set the aim of increasing validity and reliability in reporting of studies and publications, and publishers have formed similar groups. Additionally, several groups of experts across the biomedical spectrum have published experience and opinion-based guidelines and guidance on potential standardized reporting. While all these guidelines cover reporting of experiments, an important step prior to this should be rigours planning and conduction of studies. The aim of this systematic review is to identify and harmonize existing experimental design, conduct and analysis guidelines relating to internal validity and reproducibility of preclinical animal research. The review will also identify literature describing risks of bias pertaining to the design, conduct and analysis of preclinical biomedical research. search strategy PubMed, Embase and Web of Science will be searched systematically to identify guidelines published in English language in peer-reviewed journals before January 2018 (box 1). All articles or systematic reviews in English language that describe or review guidelines on the internal validity and reproducibility of animal studies will be included. Google search for guidelines published on the websites of major funders and professional organisations can be found in (Box 2). screening and annotation Unique references will be screened in two phases: screening for eligibility based on title and abstract, followed by screening for definitive inclusion based on full text. Screening will be performed in SyRF (http:// syrf. org. uk). Each reference will be randomly presented to two independent reviewers. Disagreements between reviewers will be resolved by additional screening of the reference by a third, senior researcher. Data management and reporting All data, including extracted text and guidelines, will be stored in the SyRF platform. Elements of the included guidelines will be identified using a standardized extraction form.
Reporting will follow the PRISMA guidelines as far as applicable.
IntrODuCtIOn
Within the last years, there has been growing awareness of the negative repercussions of unstandardised planning, conduct and reporting of preclinical and biomedical research. 1 2 Several initiatives have set the aim of increasing validity and reliability in reporting of (not only preclinical) studies and publications, such as CAMARADES (Collaborative Approach to Meta-Analysis and Review of Animal Data from Experimental Studies), 3 NC3Rs (The National Centre for the 3Rs), 4 SYRCLE (SYstematic Review Center for Laboratory animal Experimentation) 5 and the EQUATOR (Enhancing the QUAlity and Transparency Of health Research) network. 6 Publishers have formed similar groups (eg, The Lancet's REWARD (REduce research Waste And Reward Diligence) initiative 7 ). Additionally, several experts or groups of experts across the biomedical spectrum, both clinical and preclinical, have published experience and opinion based guidelines and guidance on potential standardised reporting. [8] [9] [10] While many of the points raised are identical or similar between these various guidelines (in fact many experts on the field are part of more than one initiative), they differ in details, rigour and show especially distinct variance in generalisability or specific challenges for a single field. While all these guidelines cover reporting of experiments, an important step prior to this should be rigours planning and conduction of studies, which faces a similar situation. 11 Consequently,
Open access
it is hard for researchers to decide which guidelines to follow, especially at the stage of planning future studies.
The aim of this systematic review is to identify and harmonise existing experimental design, conduct and analysis guidelines relating to preclinical animal research. The review will also identify literature describing (either through primary research or systematic review) risks of bias pertaining to the design, conduct and analysis of preclinical biomedical research. Reporting standards will be considered if they refer to topics that are important to consider at planning or experimental, not only at reporting, stage. This review will focus on internal validity and reproducibility of experimental design, conduct and analysis. While we realise that factors like animal housing and welfare are box Web of Science (guideline OR recommendation OR recommendations) AND ("preclinical model" OR "preclinical models" OR "disease model" OR "disease models" OR "animal model" OR "animal models" OR "experimental model" OR "experimental models" OR "preclinical study" OR "preclinical studies" OR "animal study" OR "animal studies" OR "experimental study" OR "experimental studies") PubMed ( highly important for reproducibility of experiments, they will not be considered in this initial systematic review (SR), which focuses on internal validity. It is planned to analyse the influence of animal care and use at a later point in a separate SR.
InCLusIOn AnD exCLusIOn CrIterIA
This study will include all articles or systematic reviews in English language that describe or review guidelines on the internal validity ('to what extent do the study results reflect a true cause-effect of the intervention?') and reproducibility of the design, conduct and analysis of preclinical animal studies. Articles that focus strictly focus on toxicity or veterinary drugs only will not be included. Literature not focussing on guidelines, but describing (either through primary research or systematic review) risks of bias pertaining to the design, conduct and analysis of preclinical biomedical research, will also be considered. Although reporting standards are not the key primary objective of this systematic review these will also be searched, screened and extracted, as they can contain useful information that should be considered not only at reporting, but already at planning or experimental stage.
sCreenIng AnD AnnOtAtIOn After combining the search results from all sources, potential duplicates or publication of identical guidelines by the same author group in various journals will be identified prior to screening, based on PubMed ID, digital object identifier (DOI) and title, journal and author list. Unique references will then be screened in two phases: (1) screening for eligibility based on title and abstract, followed by (2) screening for definitive inclusion based on full text. Screening will be performed in SyRF (http:// syrf. org. uk). Each reference will be randomly presented to two independent reviewers. Reviewers are not blinded to the authors of the presented record. In the first stage, two authors will screen the title and abstract of the retrieved records for eligibility based on predefined inclusion criteria (see above). The title/abstract screening stage will focus on sensitivity ('could the paper be of any interest?').
Articles included after the title-abstract screening will undergo concurrent full-text screening for definitive inclusion. We will attempt to obtain full-text versions of all included articles through open access, interlibrary loan or by contacting authors directly. Articles for which no full-text version can be obtained will be excluded from the review.
In both screening stages, disagreements between reviewers will be resolved by additional screening of the reference by a third, senior researcher, who is blind to the individual judgements of the first two reviewers.
DAtA mAnAgement
All references returned from the searches will be downloaded, with entries organised by DOI (if available, or weblink alternatively), publication date, and title. All data, box 3 extraction form
